| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 1708-1716 |
| Journal | Inflammatory Bowel Diseases |
| Volume | 16 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 2010 |
Cite this
}
Phase I, Double-blind, Randomized, Placebo-controlled, Dose-escalation Study of NI-0401 (a Fully Human Anti-CD3 Monoclonal Antibody) in Patients with Moderate to Severe Active Crohn's Disease. / van der Woude, C.J.; Stokkers, P.; van Bodegraven, A.A.; Van Assche, G.; Hebzda, Z.; Paradowski, L.; d'Haens, G; Ghosh, S.; Feagan, B.; Rutgeerts, P.; Dijkstra, G.; Jong, D.J.; Oldenburg, B.; Farhan, M.; Richard, T.; Dean, Y.; Hommes, D.W.
In: Inflammatory Bowel Diseases, Vol. 16, No. 10, 2010, p. 1708-1716.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Phase I, Double-blind, Randomized, Placebo-controlled, Dose-escalation Study of NI-0401 (a Fully Human Anti-CD3 Monoclonal Antibody) in Patients with Moderate to Severe Active Crohn's Disease
AU - van der Woude, C.J.
AU - Stokkers, P.
AU - van Bodegraven, A.A.
AU - Van Assche, G.
AU - Hebzda, Z.
AU - Paradowski, L.
AU - d'Haens, G
AU - Ghosh, S.
AU - Feagan, B.
AU - Rutgeerts, P.
AU - Dijkstra, G.
AU - Jong, D.J.
AU - Oldenburg, B.
AU - Farhan, M.
AU - Richard, T.
AU - Dean, Y.
AU - Hommes, D.W.
PY - 2010
Y1 - 2010
U2 - 10.1002/ibd.21252
DO - 10.1002/ibd.21252
M3 - Article
VL - 16
SP - 1708
EP - 1716
JO - Inflammatory Bowel Diseases
JF - Inflammatory Bowel Diseases
SN - 1078-0998
IS - 10
ER -